A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Status:
Completed
Trial end date:
2016-12-31
Target enrollment:
Participant gender:
Summary
The investigators propose to evaluate efficacy and safety of gemcitabine in the adjuvant
treatment of cholangiocarcinoma after potentially curative treatment with surgical resection.